Skip to content

A multicenter study on the efficacy and safety of individualized potassium concentration hemodialysate

A multicenter study on the efficacy and safety of individualized potassium concentration hemodialysate

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048841
Enrollment
Unknown
Registered
2021-07-18
Start date
2021-07-20
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electrolyte disturbance

Interventions

case group:Dialysis was performed with different potassium concentrations of dialysate

Sponsors

Minhang Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years old; 2. Maintenance hemodialysis patients with end-stage renal failure; 3. Regular dialysis treatment, 3 times a week, each time no less than 4 hours; 4. Participate in the experiment voluntarily and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. There is high decomposition in the body; 2. Rhabdomyolysis; 3. Tissue damage caused by burns and other causes; 4. Hemolysis; 5. Severe intake of insufficient or bad fluids; 6. Aldosteronism or aldosteronism; 7. Transfusion therapy is expected to be required during the study period; 8. Severe diarrhea, intestinal fistula and other digestive tract diseases that may cause potassium loss; 9. Work in a fever or high temperature may lead to a lot of sweating; 10. Hypokalemic periodic paralysis; 11. Other researchers believe that it is not suitable to be enrolled.

Design outcomes

Primary

MeasureTime frame
serum potassium;

Countries

China

Contacts

Public ContactXu Xudong

Minhang Hospital, Fudan University

xxdmzx@sina.com+86 18918169003

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026